Cleared Abbreviated

K210770 - Arm Blood Pressure Monitor

K210770 is the FDA 510(k) clearance for Arm Blood Pressure Monitor by Andon Health Co, Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Abbreviated 510(k) pathway after a 136-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
136d
Days
Class 2
Risk

K210770 is an FDA 510(k) clearance for the Arm Blood Pressure Monitor, Wireless Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Andon Health Co, Ltd. (Tianjin, CN). The FDA issued a Cleared decision on July 29, 2021 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Andon Health Co, Ltd. devices

Submission Details

510(k) Number K210770 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2021
Decision Date July 29, 2021
Days to Decision 136 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 125d · This submission: 136d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K210770.
Digital Blood Pressure Monitor WBP Series, including: WBP101, WBP102, WBP103, WBP104, WBP105, WBP106, WBP107
K210671 · Weony (Shenzhen) Technology Co., Ltd. · Aug 2021
Caretaker Platform, VitalStream Platform, CT5
K211588 · Caretaker Medical · Aug 2021
Wrist Blood Pressure Monitor, Blood Pressure Monitor
K210768 · Andon Health Co, Ltd. · Jul 2021
HRVWatch-Mini Wrist Monitor
K201914 · Taiwan Scientific Corporation · Jun 2021
Automatic Arm Electronic Blood Pressure Monitor
K210435 · Shenzhen Lepu Intelligent Medical Equipment Co., Ltd. · May 2021
CONTEC08A Electronic Sphygmomanometer, CONTEC08C Electronic Sphygmomanometer, ABPM50 Automatic Blood Pressure Monitor
K202757 · Contec Medical Systems Co.,Ltd · Apr 2021